Cunningham v. Lupis

CourtDistrict Court, D. Connecticut
DecidedFebruary 26, 2024
Docket3:21-cv-00273
StatusUnknown

This text of Cunningham v. Lupis (Cunningham v. Lupis) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cunningham v. Lupis, (D. Conn. 2024).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

JAMES E. CUNNINGHAM, SR., ) 3:21-cv-00273 (SVN) Plaintiff, ) ) v. ) ) FRANCESCO LUPIS, et al., ) Defendants. ) February 26, 2024

RULING ON DEFENDANTS’ MOTIONS FOR SUMMARY JUDGMENT

Sarala V. Nagala, United States District Judge. Plaintiff James E. Cunningham, Sr., proceeding pro se, filed this action pursuant to 42 U.S.C. § 1983 asserting claims relating to his medical treatment while in prison. Following initial review, the Court (Meyer, U.S.D.J), ordered all claims dismissed except for an Eighth Amendment claim for deliberate indifference to testosterone deficiency against Dr. Francesco Lupis; an Eighth Amendment claim for deliberate indifference to diabetes needs against Dr. Lupis and Nurse Chena McPherson; an Eighth Amendment claim for deliberate indifference to exercise needs against Dr. Lupis and Disability Rights Coordinator Colleen Gallagher; First Amendment retaliation claims against Dr. Lupis and Recreation Supervisor Rodolfo Alvarez; and state law claims for intentional and negligent infliction of emotional distress based on the same conduct. See Initial Review Order, ECF No. 17 at 41–42. Defendants Dr. Lupis, Gallagher, and Alvarez (together, the “Correctional Defendants”) have jointly moved for summary judgment. ECF No. 222. Defendant McPherson, who no longer works within the Department of Correction, filed a separate motion for summary judgment. ECF No. 215. For the following reasons, Defendants’ motions are GRANTED. I. FACTUAL BACKGROUND The following facts are taken from Defendants’ Local Rule 56(a)1 Statements and supporting exhibits, as Plaintiff has not complied with Local Rule 56(a).1 The incidents underlying this action occurred while Plaintiff was confined at MacDougall-

Walker Correctional Institution (“MacDougall”) and concern his medical care prior to March 3, 2021, the day he filed this action. Corr. Defs.’ Local Rule (“L.R.”) 56(a)1 St., ECF No. 222-2 ¶ 2. Gallagher, Alvarez, and Dr. Lupis are employed by the Department of Correction (“DOC”). Id. ¶ 4. Gallagher is MacDougall’s Disability Rights Coordinator, and Alvarez its recreation supervisor. Id. ¶¶ 5–7. Dr. Lupis was Plaintiff’s primary care physician at MacDougall from June 2020 through September 2022. Id. ¶ 93. Nurse McPherson is an advanced practice registered nurse (“APRN”). Def. McPherson’s L.R. 56(a)1 St., ECF No. 215-2 ¶ 2. She treated Plaintiff at MacDougall from February 26, 2019, until March 23, 2020, before her transfer to

1 All Defendants provided Plaintiff a notice in compliance with Local Rule 56(b) which informed him of the requirements for filing his papers in opposition to the motion for summary judgment under Local Rule 56. See ECF No. 215-8; ECF No. 222-10. Local Rule 56(a)1 and 3 provide that: “Each material fact set forth in the Local Rule 56(a)1 Statement and supported by the evidence will be deemed admitted . . . unless such fact is controverted by the Local Rule 56(a)2 Statement,” and “each denial in an opponent’s Local Rule 56(a)2 Statement[] must be followed by a specific citation[.]” Instead of reproducing each statement from Defendants’ Local Rule 56(a)1 Statement and indicating whether he admits or denies that statement with a citation to admissible evidence, Plaintiff has (1) simply copied and edited many of the Correctional Defendants’ statements to reflect his views; and (2) failed to file a statement in response to Defendant McPherson’s motion at all. Compare, e.g., Corr. Defs.’ L.R. 56(a)1 St., ECF No. 222-2 ¶ 15 (“If the inmate is not satisfied with the response . . . the inmate must file a Level 1 grievance[.]”); with Pl.’s L.R. 56(a)2 St., ECF No. 232 ¶ 15 (“You cannot file a grievance on health issues[.]”); see also Pl.’s Opp. to Def.’s McPherson’s Mot. Summ. J., ECF No. 233 (containing no Local Rule 56(a)2 Statement).

Plaintiff consciously disregarded his responsibility to cite admissible evidence in support of his denials, stating “I know you don’t have to read. But if I tried to document each page it would take hundreds of pages.” ECF No. 232 at 5. He instead submits more than 1,200 disorganized pages of exhibits which include medical records, grievances, emails, internet articles, and disciplinary reports interspersed with his own commentary handwritten in the margins. See ECF Nos. 235–36. Thus, the facts set forth in Defendants’ Local Rule 56(a)1 Statements, where supported by the cited records, are deemed admitted. See Jusino v. Barone, No. 3:22-cv-490 (SRU), 2023 WL 6379342, at *2 n.2 (D. Conn. Sept. 29, 2023) (holding in pro se action that “to the extent a party’s Local Rule 56(a)2 Statement does not comply with Local Rule 56, I may consider a Local Rule 56(a)1 statement of fact to be admitted if supported by evidence”); see also Wu v. Nat’l Geospatial Intel. Agency, No. 3:14-cv-1603 (DJS), 2017 WL 923906, at *2 (D. Conn. Mar. 8, 2017) (similar). another correctional facility. Id. ¶¶ 2, 4. Plaintiff has been diagnosed with type 2 diabetes, hypertension, hypotestosteronemia (testosterone deficiency), hyperlipidemia, hypothyroid, morbid obesity, and osteoarthritis. Corr. Defs.’ L.R. 56(a)1 St. ¶ 94. Plaintiff’s claims concern treatment related to his testosterone

deficiency, diabetes, and his exercise needs. A. Testosterone Deficiency Testosterone is a steroid hormone that is produced in the adrenal glands of males and females and in the male testes. Id. ¶ 96. Low testosterone occurs naturally as part of the aging process in men, and can affect mood, sex drive, body and facial hair, muscle and body mass, and teste size—but there is no scientific evidence that low testosterone causes death, serious injury, or physical pain. Id. ¶¶ 97, 105. In certain circumstances, combined with a decrease in vitamin D and calcium, low testosterone can contribute to an increased risk of osteoporosis. Id. ¶ 98. Low testosterone is not, however, a definitive cause of osteoporosis and providing testosterone to a patient who has osteoporosis does not cure osteoporosis. Id. ¶¶ 99–100.

Prior to July 18, 2020, Plaintiff was receiving chronic testosterone therapy in the form of 200 milligram shots of depo testosterone every other week. Id. ¶ 106. On July 18, 2020, Plaintiff asked Dr. Lupis to renew his depo testosterone shots, but Dr. Lupis decided to stop the shots because Plaintiff’s April 2020 blood tests created concerns that the shots were elevating Plaintiff’s hemoglobin/hemocrit levels and resulting in polycythemia, a condition in which the volume percentage of red blood cells are elevated in a patient’s blood. Id. ¶¶ 107–09. Polycythemia increased Plaintiff’s risk of developing deep vein thrombosis and a pulmonary embolism, and his risk of sudden death. Id. ¶ 110. Plaintiff was at an increased risk of these events because he is morbidly obese, diabetic, and uses a wheelchair instead of walking. Id. ¶ 111. In addition, Dr. Lupis found no clear indication that continued testosterone injunctions were necessary and was aware of no scientific or medical evidence that low testosterone could harm Plaintiff. Id. ¶ 112.2 On September 8, 2020, Plaintiff was seen by an endocrinologist concerning his diabetes, at which the use of exogenous testosterone was considered. Id. ¶ 113. The endocrinologist did

not recommend that Plaintiff resume testosterone therapy, however. Id. ¶ 114. Instead, he recommended that various tests be performed first, and that a decision be made based on those test results. Id. ¶¶ 115–16. On October 6, 2020, Dr. Lupis reviewed the results of new blood tests. Id. ¶ 117. He observed that Plaintiff was still not producing sufficient testosterone and that Plaintiff’s body was suppressing cortisol production because Plaintiff had been a frequent steroid user in the past. Id. ¶ 118. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Day v. Chaplin
354 F. App'x 472 (Second Circuit, 2009)
United Mine Workers of America v. Gibbs
383 U.S. 715 (Supreme Court, 1966)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Carnegie-Mellon University v. Cohill
484 U.S. 343 (Supreme Court, 1988)
McCarthy v. Madigan
503 U.S. 140 (Supreme Court, 1992)
Booth v. Churner
532 U.S. 731 (Supreme Court, 2001)
Porter v. Nussle
534 U.S. 516 (Supreme Court, 2002)
Woodford v. Ngo
548 U.S. 81 (Supreme Court, 2006)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Tracy v. Freshwater
623 F.3d 90 (Second Circuit, 2010)
Hill v. Curcione
657 F.3d 116 (Second Circuit, 2011)
Hathaway v. Coughlin
99 F.3d 550 (Second Circuit, 1996)
Chance v. Armstrong
143 F.3d 698 (Second Circuit, 1998)
Neal v. Goord
267 F.3d 116 (Second Circuit, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
Cunningham v. Lupis, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cunningham-v-lupis-ctd-2024.